MeD-Seq, a novel method to detect DNA methylation genomewide

Next-Generation Sequencing (NGS) is opening new avenues for epigenetic research by unleashing mechanisms that shape cell- and disease-specific gene expression programs. Although technical challenges still exist, having NGS technologies featuring simple workflow, high-throughput capability, and a high-quality readout with minimal sequencing depth will help to enable further breakthroughs.

In this webinar, Dr. Wilfred van IJcken describes and discusses a newly developed method for genome-wide detection of DNA methylation.

This webinar covers the following topics:

  • Background on DNA methylation
  • Key aspects of the novel MeD-Seq method
  • Validation data of MeD-Seq
  • Real showcase on cervical cancer after hrHPV infection

      Wilfred van IJcken, PhD


      Wilfred van IJcken, PhD
      Methylomics, Board member and Manager of Erasmus Center for Biomics